TECH CONNECTTurning Ideas into Opportunities
| |
| Monthly news & updates October 31, 2022
| |
|
| FY 2023STATISTICS
YEAR TO DATE
| |
| U.S. Patents
Issued
21
*includes end-user software and materials licenses along with conventional technology licenses
| |
|
CTTC breaks records in leveraging innovation and discovery at Vanderbilt
The Vanderbilt Center for Technology Transfer and Commercialization generated more than $100 million in licensing revenue—quadruple its annual average—and reviewed more than 1,000 material transfer agreements and facilitated nearly 300 U.S. patent applications in the 2022 fiscal year.
“Commercialization and entrepreneurship amplify and accelerate the impact of Vanderbilt research and scholarship, allowing the university to provide direct, deeply transformative and scalable benefits to society,” Chancellor Daniel Diermeier said. “We are proud to be fostering a culture where trans-institutional collaboration and innovation are top priorities.”
CTTC provides professional commercialization services to the Vanderbilt University and Vanderbilt University Medical Center communities to optimize the flow of innovation to the marketplace and generate revenue that supports future research activities. CTTC serves as a conduit for the transfer of promising intellectual property to industry; contributing to regional economic development by licensing locally and supporting new venture creation and encouraging greater translational research collaborations between academia and industry.
“The dramatic growth in revenue and output generated by CTTC signifies a new era of discovery and a broadening innovation ecosystem at Vanderbilt,” Provost C. Cybele Raver said. “Through our investments in industry collaboration, new ventures, and enhancing faculty resources, we are serving as a catalyst for innovation that will continue to yield bold solutions to the world’s most pressing problems.”
| |
|
|
Event Alert: ASPIRE to Innovate Fellowship Faculty Information Session
| |
Working with the Biomedical Research Education and Training (BRET) Office, Vanderbilt’s Center for Technology Transfer and Commercialization (CTTC) is soliciting technologies from faculty researchers of all ranks and tracks in the School of Medicine Basic Sciences that could form the basis of a startup company. This is done via BRET’s ASPIRE to Innovate Fellowship program, which has two primary objectives:
- to enable the commercialization of technologies discovered at Vanderbilt University and
- to provide a biomedical Ph.D. scientist with a structured training opportunity to learn how to transform a technology into a company. More information can be found here.
Additional information will be provided during a webinar scheduled for Tuesday, November 15th, 2-3 pm with a Q&A session to follow. Please register below to attend the information session and learn more about the program. To schedule a consultation, please contact George Wilson at george.wilson@vanderbilt.edu
| |
The Women In Science Translational Research Symposia was launched in 2020 by Deerfield Management as an avenue to equip female scientists with the skills needed to advance their groundbreaking discoveries to market. One of the goals of the symposium is to address the gender gap in innovation and change the paradigm through educational programming and networking. By attending this yearly symposium, attendees benefitted from a better understanding of the business side of commercialization.
In the two years since its launch, there have been 134 women participants with 9 coming from Vanderbilt University and VUMC. At the 2022 conference, Dr. Lori Coburn, an Assistant Professor from the Department of Medicine and Gastroenterology at Vanderbilt University Medical Center attended in person.
"I am grateful for the opportunity to attend this Symposia. With my focus on clinically translatable research, the insights, examples, and lessons learned for successful translation to commercialization will be invaluable” said Dr. Coburn.
The Vanderbilt community continues to value Deerfield’s commitment to addressing the gender gap in innovation.
| |
| CTTC Welcomes Sandy DeWald
| |
Sandy DeWald joined Vanderbilt University in September 2022 and is the Assistant Director for Industry Collaborations in the Office of the Vice Provost for Research, co-located with the Center for Technology Transfer and Commercialization.
Her role will focus on identification, cultivation, and solicitation of corporations by managing market intelligence for the stewardship of organizational research and development (R&D) relationships and will be involved in supporting corporate R&D collaborations across the university’s schools and colleges.
Sandy brings extensive market knowledge in the commercialization of new products. With over 20 years of experience in the manufacturing industry, she has developed and launched hundreds of new products for multiple market segments including automotive, construction, mining, consumer goods, oil & gas, metal fabrication, and warehouse operations.
She holds a Bachelor’s degree in Biology and English from the University of South Carolina-Aiken and an MBA from Union University.
| |
Webinar Opportunity: Cosylab and Deerfield Management are hosting an educational webinar on Boron Neutron Capture Therapy
In partnership with Cosylab, Deerfield will be hosting a free webinar on Boron Neutron Capture Therapy (BNCT) on November 9th. BNCT is an exciting cancer treatment modality being deployed to treat patients worldwide. The webinar will feature Avi Kometz, a Partner on the Deerfield team, and will focus on designing, operating, and financing a BNCT center, highlighting what expertise are required.
You will have the opportunity to discuss with world-renowned experts:
- Naonori Hu, Ph.D., Assistant Professor at Osaka Medical and Pharmaceutical University Kansai BNCT Medical Center
- Avi Kometz, M.D., Partner on the Medical Technologies Team at Deerfield Management
- Sandro Rossi, General Director of The National Centre for Oncological Hadrontherapy (CNAO)
- Mikko Tenhunen, Chief Physicist and Professor at Helsinki University Hospital Comprehensive Cancer Centre
| |
| Five Vanderbilt Technologies Earn Patent Protection in October
| |
|
|
| |
|
2-Beta-Naphthyl-Acetic Acid Analogs as AKR1C3 Inhibitors and Methods of Using Same
| |
|
Cartridge Systems, Capacitive Pumps and Multi-Throw Valves and Pump-Valve Systems and Applications of Same
| |
|
Prosthetic Knee with Swing Assist
| |
|
Methods of Inhibiting Tumor Metastasis
| |
|
Robots and Robotic Systems for Fluid Handling and Transport of Biodevices and Applications of Same
|
| |
|
Technology Spotlight:Surgical Guide for Intraoral Vertical Ramus Osteotomy
| |
Vanderbilt researchers have developed a novel surgical guide for intraoral vertical ramus osteotomy (IVRO) that helps to preserve the proximal segment medial pterygoid attachment and avoid injury to the inferior alveolar neurovascular bundle during the procedure.
Technology and IP Status:Prototypes of the device have been made and are being tested.
A patent application has been filed for the device.
| |
Below is a sampling of the interactions that have taken place in our office and with our staff over the last month.
| |
- Attended a training program on GlobalData, a data analytics platform featuring intelligence on the pharmaceutical and medical device industries
- Attended Tennessee Biotechnology Investment and Policy Roundtable meeting hosted by a local biotech investor
- Attended presentation on key insights into the state of startups in the southeast in 2022 hosted by a local venture capital firm
- Attended the Innovation Open Mic competition hosted by the Wond’ry
- Attended presentation on equity considerations in startup licenses from universities hosted by a local law firm
- Attended the annual retreat for the CTTC New Ventures team
- Attended a presentation on innovation in healthcare, consumerism, and technology hosted by the Nashville Healthcare Council
- Attended the 2022 Next Awards hosted by the Nashville Entrepreneur Center
- Attended board of directors meeting of nPhase, Inc.
- Attended presentation on venture capital deployment in Nashville hosted by the National Venture Capital Association
- Attended the annual meeting of the Global Consortium of Entrepreneurship Centers
- Attended Downtown Nashville Partnership Annual Meeting
- Attended the Nashville Area Chamber of Commerce, 175 years of the Chamber, breakfast event
- Attended a meeting with VUMC Office of Legal Affairs to discuss any intellectual property concerns related to the transfer of Galagos Monkeys to another academic institution
| |
- Executed a Confidentiality Agreement with a biopharmaceutical company interested in therapeutics for the treatment of trigeminal neuralgia developed by the Vanderbilt Drug Repurposing Program
- Executed a Confidentiality Agreement with a pharmaceutical company interested in therapeutic delivery technologies developed by Craig Duvall from the Department of Biomedical Engineering
- Executed a Confidentiality Agreement with a large medical products company interested in synthetic foam wound dressing technology developed by Craig Duvall and Scott Guelcher from the Department of Biomedical Engineering
- Executed a non-exclusive license with a biotech company for a cancer mouse model developed at Vanderbilt
| |
- Visited with a Vanderbilt startup as a periodic touch-base exercise
- Met with Naomi Taylor and colleagues of IRIS Center in Peabody College to learn more about the Center’s professional development educational modules and to explore commercialization
- Facilitated discussions exploring collaborations between VUMC Health Professional Solutions and a healthcare venture capital firm
- Submitted capability proposal to an independent aviation company regarding potential collaboration areas
- Held discussions with Lawrence Livermore National Laboratory regarding new derivative antibodies created for the neutralization of COVID-19
- Held a call with the Conflict of Interest and Commitment Management Office to discuss CTTC’s workflow to identify institutional conflicts of interest
- Met with faculty to discuss potential Ancora proposal submissions
- Met Florian von Groote-Bidlingmaier, EVP Global Health and Clinical Development at Evotec, to discuss the anti-infectives portfolio
- Held a diligence call with a nutraceutical company interested in commercializing the gut health compound created by Fang Yan of the Department of Pediatrics
| |
- Hosted attorneys from two of our law firms and met with relevant innovators to discuss patent prosecution strategies
- Presented a lecture on Technology Transfer at Vanderbilt University and VUMC
- Presented a lecture on Effective Negotiations to Grayson McClain’s Technology-Based Entrepreneurship course for undergraduate students
- Presented a training session on CTTC and Intellectual Property to the first cohort of Innovation Ambassadors
- Hosted Jay Harrison’s presentation on Xtremis at the Entrepreneurship Advisory Council (EAC)
- Presented update on the Young American Leaders Program class of 2022 project: Nashville Coalition Responsible for Equitable Skills Training (CREST)
- Hosted a leading online retailer engineering team to discuss smart grid technology, intelligent transportation systems, critical infrastructure, and freight network resilience
- Participated in an NSF Mobility Engine, 2-day workshop as a member of the Tech-to-Market workgroup
- Gave a presentation to VUMC’s Office of Contracts Management on IP considerations in reviewing research agreements
- Hosted the monthly Ancora business meeting with CTTC and Deerfield
- Hosted 3DC visit to Vanderbilt for Ancora Project Team Kickoff Meeting
- Hosted an international vaccine development company interested in developing vaccines with various VU and VUMC faculty members
| |
View our updated Vanderbilt Vaccine Center Antibody Pipeline.
The pipeline highlights a listing of fully human antibodies by target disease, availability by field, and stage of development. Links to scientific publications are also included.
| | 
View our updated Medical Device Pipeline.
The catalogue highlights medical device technologies currently in the pipeline for commercialization at Vanderbilt University. This Pipeline has more than 100 technologies in 12 categories from 40 research groups.
| |  |
| | |
|
|
|
